Sat.Apr 08, 2023 - Fri.Apr 14, 2023

article thumbnail

A Biosimilar Wave Looms Large Over US Biologics Market

Drug Topics

As more adalimumab biosimilars are poised to enter the market, manufacturers, payers, and patient advocates are preparing to navigate potentially turbulent waters.

464
464
article thumbnail

Solutions to Streamline Inventory Management

Drug Topics

Autofill programs and metrics reporting can help pharmacists streamline their inventory management.

469
469
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Smarter Collaboration Helps Pharmacy Professionals Achieve Their Goals

Pharmacy Times

Pharmacy professionals can bring in the right people at the right time to identify needed changes and develop an action plan.

123
123
article thumbnail

FDA should remain the authority on the safety and effectiveness of medicines

PhRMA

Recent district court rulings set an alarming precedent that calls into question the authority of the U.S. Food and Drug Administration (FDA) to determine the safety and effectiveness of new medicines.

FDA 321
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

What’s pharma doing wrong to improve trial diversity? ‘Everything’

PharmaVoice

Pharma’s missing the mark when it comes to recruiting Black patients, and Ricki Fairley, CEO of The Black Breast Cancer Alliance, reveals what’s needed.

246
246
article thumbnail

Hundreds Of Pharma Executives Sign Open Letter Condemning Mifepristone Ruling

Drug Topics

Over 400 pharmaceutical employees and executives signed an open letter in a show of solidarity with the FDA, but some say that big pharma’s actions helped lead to this moment in the first place.

FDA 469

More Trending

article thumbnail

CMS guidance on IRA price setting process doubles down on bad policy

PhRMA

As part of the implementation of the Inflation Reduction Act (IRA), the Centers for Medicare & Medicaid Services (CMS) issued draft guidance on the process for setting the price of medicines. The process is in no way a “negotiation,” and CMS chose to go beyond what was outlined in the statute, taking the most extreme stance to sweep in as many medicines as possible and be as punitive as possible.

276
276
article thumbnail

Fighting vaccine hesitancy may require a new approach from pharma

PharmaVoice

The COVID-19 pandemic highlighted an ongoing problem of vaccine hesitancy undermining public health efforts. One way pharmas can help is to change the narrative.

Vaccines 147
article thumbnail

AAP Members Celebrate Their Independent Pharmacy Stories

Drug Topics

Four independent pharmacists shared their journeys to become pharmacy owners.

article thumbnail

Study Shows Psilocybin Therapy Improves Major Depressive Disorder in Patients With Cancer

Pharmacy Times

Based on the study results, investigators concluded that there is justification for a randomized clinical trial.

178
178
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

New global analysis shows patient access challenges around the world

PhRMA

Today PhRMA released a new report that analyzes the share of new medicines that are available in over 70 countries and how long patients wait to receive them. The Global Access to New Medicines Report includes comprehensive comparisons across countries in the G20, Organization for Economic Co-operation and Development (OECD) and several geographic regions.

269
269
article thumbnail

Where one unicorn struggled, another biotech is aiming for a diabetes win

PharmaVoice

Intarcia looked poised to break into a lucrative diabetes implant market but has been dogged by safety issues — now Vivani thinks it’s found a way to succeed.

147
147
article thumbnail

Breaking: HHS Extends PREP Act Authority for Pharmacists, Pharmacy Technicians

Drug Topics

HHS Secretary Xavier Becerra will release an amendment to the declaration in the coming weeks.

469
469
article thumbnail

12 Skills Pharmacy Students Can Apply to Become Leaders in Their Practice

Pharmacy Times

Pharmacists serve as advocates to optimize patient pharmaceutical care, advance the profession, and positively influence the community.

149
149
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

What they are saying: Experts reinforce that TRIPS waiver expansion is harmful and unnecessary

PhRMA

At the direction of the U.S. Trade Representative, the U.S. International Trade Commission (USTIC) is investigating the impact of a proposed waiver of intellectual property (IP) protections for COVID-19 diagnostics and therapeutics under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). Public submissions to the USITC from experts across patient groups, academia, public health, labor and the private sector make clear that, much like the orig

Vaccines 264
article thumbnail

In counties with more Black doctors, Black people live longer, ‘astonishing’ study finds

STAT

Black people in counties with more Black primary care physicians live longer, according to a new national analysis that provides the strongest evidence yet that increasing the diversity of the medical workforce may be key to ending deeply entrenched racial health disparities. The study , published Friday in JAMA Network Open, is the first to link a higher prevalence of Black doctors to longer life expectancy and lower mortality in Black populations.

145
145
article thumbnail

Case Study: Treating Infants for Cannabis Exposure

Drug Topics

As more and more states legalize recreational marijuana, caregivers need to be vigilant about keeping products out of the reach of children.

468
468
article thumbnail

Google, Microsoft and startups test out generative AI in healthcare

Fierce Healthcare

Google, Microsoft and startups test out generative AI in healthcare hlandi Fri, 04/14/2023 - 08:04

144
144
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

A guide to MedPAC’s Part B vote today

PhRMA

Today, the Medicare Payment Advisory Commission (MedPAC), an independent congressional agency that advises Congress on issues related to the Medicare program, will vote on draft recommendations related to Part B. Unfortunately, these recommendations include proposals that could give the Centers for Medicare and Medicaid Services (CMS) new authority to make one-size-fits-all value judgments based on flawed cost-effectiveness standards, and to come between doctors and patients in deciding which tr

256
256
article thumbnail

Demand for home health aides is soaring. So why are they still so undervalued?

STAT

On most days around 2pm, home health aide Duane Crichlow can be found in an apartment in Sunset Park, Brooklyn, playing catch with his client — a man in his 30s with a developmental disability who is quick to give Crichlow hugs and kisses. If it’s nice outside, Crichlow will walk his client, who is nonverbal and in a wheelchair half the time, down three flights of stairs, hauling the wheelchair back and forth separately.

145
145
article thumbnail

Reducing the Misuse of Antibiotics in Malaria and Dengue

Drug Topics

Antimicrobial stewardship remains important in tropical diseases such as malaria and dengue.

469
469
article thumbnail

ADHD Medication Shortage and the National Fallout: What to do Now?

Pharmacy Times

Pharmacists are crucial in supporting patients with attention-deficit hyperactivity disorder as shortages of Adderall continue.

145
145
article thumbnail

About 800,000 nurses planning to leave the profession by 2027, data show

Fierce Healthcare

About 800,000 nurses planning to leave the profession by 2027, data show dmuoio Fri, 04/14/2023 - 14:25

137
137
article thumbnail

The Biden administration will hang on to some Covid pandemic emergency powers

STAT

WASHINGTON — Even though the Biden administration is ending its highest-profile Covid-19 emergency declaration next month, it’s still going to hold on to some pandemic-era powers. The Department of Health and Human Services gave governors a heads-up on Friday that it is planning to keep pharmacists’ ability to administer Covid-19 and flu vaccines past the end of the public health emergency.

Vaccines 142
article thumbnail

FDA Gives Drug Gohibic Emergency Use Authorization to Treat COVID-19

Drug Topics

The FDA granted the EUA based on the phase 3 trial results that demonstrated vilobelimab's efficacy compared to placebo, with a 23.9% relative reduction in all-cause mortality from COVID-19 at 28 days.

FDA 469
article thumbnail

Overcoming Our Blind Spots: Pharmacists Can Help Address Human Trafficking

Pharmacy Times

Being observant and knowing how to ask screening questions are critical to identifying red flags.

139
139
article thumbnail

5 minutes with — Genlantis Diagnostics’ Ahsan Awan

PharmaVoice

A serial entrepreneur, futurist and industry disrupter, the VP of clinical development and digital health is always on the quest to build a “better mousetrap.

130
130
article thumbnail

Opinion: Harvey Washington Wiley campaigned for food and drug safety in the early 20th century. Digital mental health needs its own Wiley moment

STAT

Prior to the early 20th century, America had no regulation of medications or food additives. Formaldehyde was used to preserve meat, morphine was included in infant “soothing syrups,” and marketing, not science, drove the promotion of tonics and medications. The 1906 Food and Drug Act was the first in a series of consumer protection laws focused on setting standards for safe and effective medications and food additives.

FDA 135
article thumbnail

A Return to Normalcy

Drug Topics

Despite a massive COVID-19 vaccination campaign, many still fear a return to normal.

Vaccines 467
article thumbnail

Updates on 503A Compounding: The Impact of Drug Shortages

Pharmacy Times

The FDA’s temporary Guidance for 503A compounding of shortage drugs was meant to be temporary and withdrawn once COVID-19 ended.

article thumbnail

Woman of the Week: uMotif’s Julia Lakeland

PharmaVoice

The chief product officer’s work in transforming clinical trial technology is driven by people.

130
130
article thumbnail

Humana puts $40M toward affordable housing

Fierce Healthcare

Humana puts $40M toward affordable housing pminemyer Fri, 04/14/2023 - 15:52

128
128
article thumbnail

How Pharmacists Should Talk So Vaccine-Hesitant Parents Listen

Drug Topics

Vaccine hesitancy exists on a spectrum, but with the right tools, pharmacists can provide education and reassurance to parents and caregivers.

Vaccines 466